1. Home
  2. EYPT vs SBC Comparison

EYPT vs SBC Comparison

Compare EYPT & SBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SBC
  • Stock Information
  • Founded
  • EYPT 1987
  • SBC 2000
  • Country
  • EYPT United States
  • SBC United States
  • Employees
  • EYPT N/A
  • SBC N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SBC
  • Sector
  • EYPT Industrials
  • SBC
  • Exchange
  • EYPT Nasdaq
  • SBC NYSE
  • Market Cap
  • EYPT 390.0M
  • SBC 425.8M
  • IPO Year
  • EYPT 2005
  • SBC N/A
  • Fundamental
  • Price
  • EYPT $5.81
  • SBC $3.50
  • Analyst Decision
  • EYPT Strong Buy
  • SBC
  • Analyst Count
  • EYPT 7
  • SBC 0
  • Target Price
  • EYPT $24.00
  • SBC N/A
  • AVG Volume (30 Days)
  • EYPT 685.1K
  • SBC 27.3K
  • Earning Date
  • EYPT 05-07-2025
  • SBC 05-23-2025
  • Dividend Yield
  • EYPT N/A
  • SBC N/A
  • EPS Growth
  • EYPT N/A
  • SBC 15.50
  • EPS
  • EYPT N/A
  • SBC 0.48
  • Revenue
  • EYPT $56,042,000.00
  • SBC $205,415,542.00
  • Revenue This Year
  • EYPT N/A
  • SBC $5.59
  • Revenue Next Year
  • EYPT N/A
  • SBC $19.05
  • P/E Ratio
  • EYPT N/A
  • SBC $6.63
  • Revenue Growth
  • EYPT 12.04
  • SBC 6.13
  • 52 Week Low
  • EYPT $3.91
  • SBC $2.62
  • 52 Week High
  • EYPT $21.26
  • SBC $36.52
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 48.48
  • SBC N/A
  • Support Level
  • EYPT $5.75
  • SBC N/A
  • Resistance Level
  • EYPT $7.45
  • SBC N/A
  • Average True Range (ATR)
  • EYPT 0.47
  • SBC 0.00
  • MACD
  • EYPT -0.05
  • SBC 0.00
  • Stochastic Oscillator
  • EYPT 22.35
  • SBC 0.00

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SBC SBC MEDICAL GROUP HOLDINGS INCRPRTD

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). Company provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.

Share on Social Networks: